Bio-Techne (TECH) Net Cash Flow Growth (1y) (2010 - 2026)
Bio-Techne (TECH) Net Cash Flow Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -88.82% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 301.06% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 453.08% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -125.22% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Bio-Techne | 11.23 Bn | 11.02 Bn | 208.29 Mn | 206.51% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 206.51% |
| Dec 31, 2025 | 708.09% |
| Sep 30, 2025 | -152.28% |
| Jun 30, 2025 | 23.69% |
| Mar 31, 2025 | -395.14% |
| Dec 31, 2024 | 79.40% |
| Sep 30, 2024 | 231.96% |
| Jun 30, 2024 | -87.88% |
| Mar 31, 2024 | 130.53% |
| Dec 31, 2023 | -177.20% |
| Sep 30, 2023 | -606.10% |
| Jun 30, 2023 | 195.43% |
| Mar 31, 2023 | 15.36% |
| Dec 31, 2022 | -163.62% |
| Sep 30, 2022 | 181.41% |
| Jun 30, 2022 | 43.84% |
| Mar 31, 2022 | -337.40% |
| Dec 31, 2021 | 232.24% |
| Sep 30, 2021 | -92.89% |
| Jun 30, 2021 | 223.10% |